Member Info for BlahBlahDoh

More likely due to the likelihood that the European Central Bank will probably accelerate interest rate rises to help out Credit Suisse. This started with US regulation cancellation under the previous administration, which eventually lead to the SVB bank failure, and now looks likely to cause a hike in the cost of borrowing worldwide, and possibly some flight of capital from stocks to interest bearing investments. AAF may be affected in terms of the cost of borrowing, but I don't think it's a major concern

Turning a profit is years away, and an elusive moving target. Some analysts estimate 3 years, but that's a recent revision from late 2025, and I'd guess a later date rather than an earlier one, based on what generally happens - hype tends towards the positive rather than the realistic. Having said that, the products continue to look world leading, indeed world changing, and deals with both leading robotic surgery companies supports that. If the post Covid boom can be sustained, the recent acceleration in uptake might go into overdrive. Logistically, CREO now seems well set up to facilitate that. Fingers crossed (unless you're a surgeon)

Management bought an aggregate total of roughly £2.1m worth of the new shares. Pretty big vote of confidence from the Fat Cats, keeping the SP lively

As well as world leaders, Intuitive Surgical, CREO are working with their rivals, the British company CMR surgical, in Cambridge who claim to have a more flexible and efficient solution, and which is introducing robots to NHS hospitals imminently. A deal was signed just 5 months ago to integrate certain aspects of Creo's technology with their system. Royalties and licensing agreed but not disclosed

"If these instruments can be used in conventional surgery then they must also be ideal for robotic surgery and you don’t have to train the robot. And almost all the robotic surgery in the world is controlled by one company so only one door to kick down. "

The company signed a deal with Intuitive Surgical 10 months ago. Their system is really robot-assisted surgery, meaning a robot is operated by a surgeon from a console. It is already in the field with approval granted for a few procedures. Revenue from the deal will initially come in milestone payments, assuming they can be reached. Presumably these are based on successfully combining the CREO tools and the robot for a specific new procedure and ultimately gaining FDA approval

Just been announced that the total fundraising was £33.7 million, probably enough to reach profitability if growth assumptions are realistic. Presumably impending dilution was the main drag on the SP, so we potentially enter a new trend. Trading in the massive volume of new shares starts tomorrow. An initial downward movement might be expected, but who knows in this market

Makes sense Theorist, unlike some of the recent glib comments. There must be a suspicion they over-egged the recent good-news blitz in order to get the funding round away, but hopefully underlying growth really is gearing up and the improved financial footing will allow the SP to gain some traction. Having said that, it's all over the place at the moment!

with yesterdays news. Not the loss, that was expected. Not the CFO leaving, which was unexpected. It was the lack of any sort of information about the ongoing court case beyond the cost so far. We know it was the sole cause of last years loss. We need to have some idea of the impact it will have on this year and the long term future, and we got nothing

"they probably agree $150m and made the numbers work."
If that was the case, there would be no need for a transfer of IP, they could simply have waffled about an unfortunate misunderstanding and a partial unintentional infringement to the tune of $150m. Instead they specifically (i.e. forensically) stated which part was for the asset sale. If you assume this was just playing with numbers, and they really got $150m for infringement (still less than BT was guiding) then you have to value the transferred IP at zero, or something extremely low, which seems unreasonable.

@Henry Your disappointment with a "USD 150 million" settlement is understated, I think. Since more than half of that figure was for a SALE OF ASSETS, i.e. completely separate from infringement, the true amount is FAR lower. I believe this part of the deal was included purely to make the figure look higher than it actually is.

Heads up that the SP will possibly experience some volatility in reaction to a new president to replace Buhari, and the expected currency devaluation which is likely to follow, as mentioned by Joberalo a couple of weeks ago

So minimum fundraise of £25m and open offer of £5m at 20p = at least 150m new shares, on top of about 180m currently in issue. Can see this falling below the offer price once the dust has settled, given the "jam" is still estimated at 3 years away, and quite possibly more?

True Shear, the scale-up has been consistent, but worth noting that Edison estimate that, despite this, breakeven has slipped slightly further into the future. Takeover makes a lot of speculative sense - bigger pockets and more powerful management could probably accelerate profitability here.

"woefully incorrect analysis"
They haven't settled for a few hundred million, the settlement includes an unexpected sale of assets, that's the only significant revenue from it. The rewards from the litigation which relate to the actual dispute, after costs, are financially negligible, the main value being the validation of the remaining IP.

Yeah, but also remember CF's timescales for disposal at the time, long since miseed. I wouldn't place too much reliance on his specific hints and promises, but the underlying business is genuinely good

"we now expect Creo to reach net profitability in H126 compared to FY25 previously. However, we expect underlying EBITDA, a key metric used by Creo, to turn positive in H225 (£1.1m in FY25).

Creo ended FY22 with gross cash of £13.1m (estimated net cash position of £6.3m excluding our forecast total debt of £6.8m), which, based on our projected burn rates, should be sufficient to fund operations into Q223. We anticipate the need to raise another £25m (FY23: £15m and FY24: £10m), which we model as illustrative debt, to support its growth plan."

https://www.edisongroup.com/research/progressing-on-all-fronts-2/31884/

Seems to imply no funding will be needed for 2025, presumably because it will be close to breakeven.

Elsewhere in the report they warn that dilution due to fundraising is a distinct possibility in Q2 2023. So great value at current price, but possibly even cheaper very soon? Odd situation

" As an experienced litigant over three decades it was what I expected all along and it could have been a lot worse, which is why I sold temporarily."
Get your story straight. You claimed to have sold some at the higher price, remember? It is only long after the price had fallen due to the second RNS that you claimed to have sold the lot. A very odd and indecisive way to behave for someone who"expected" such a result. Scarcely believable

"So with my average of 34p do I have to accept I'm never going to make any money from this?"

No. The market is unpredictable, and the SP has been a lot higher than that in the past. There are various scenarios where this could jump - a new virus, government initiative, even just a change in market sentiment. Anyway, your short term aim should be reducing paper losses, and in those terms it's on fire. It started the year on 10p, so walk on, with hope in your heart

"blatant pump RNS on 6th Jan and then dump rns on the 9th"
That seems like a mischaracterisation. Compared with what Elon Musk just got away with, they were blameless. The first RNS was simply factually accurate, the second was good guidance, but far too wide open to interpretation in the light of months of contrary guidance, but it can't honestly be described as a "dump"

FH, under your interpretation the litigation funders are going to take a cut of the IP sale, despite it not being part for the litigation, which was about infringement. I agree that is the way they have worded it, but if true it makes the deal look even worse.

Regarding civility, please stop asking for help without making any effort, and when someone helps you, pay attention, don't continue inventing nonsense, because it's rude, disrespectful, and boring.